These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 2748559)

  • 41. [Short-term intensive therapy of destructive pulmonary tuberculosis].
    Bondarev IM; Zhigalina LI; Kunichan AD
    Probl Tuberk; 1980 Dec; (12):57-9. PubMed ID: 7220536
    [No Abstract]   [Full Text] [Related]  

  • 42. [Advances and principles in tuberculostatic therapy].
    Bethge H
    Internist (Berl); 1971 Aug; 12(8):328-31. PubMed ID: 4328130
    [No Abstract]   [Full Text] [Related]  

  • 43. [Effectiveness of the endobranchial administration of antibacterial drugs in the combination treatment of tuberculosis].
    Golenitskiĭ AI; Koval' NN; Iareshko AG
    Probl Tuberk; 1979 May; (5):69-70. PubMed ID: 471999
    [No Abstract]   [Full Text] [Related]  

  • 44. Tuberculosis in the elderly: treating the "white plague".
    Iseman MD
    Geriatrics; 1980 Mar; 35(3):90-107. PubMed ID: 7353794
    [No Abstract]   [Full Text] [Related]  

  • 45. Two excellent management tools for national tuberculosis programmes: history of prior treatment and sputum status at two months.
    Trébucq A; Rieder HL
    Int J Tuberc Lung Dis; 1998 Mar; 2(3):184-6. PubMed ID: 9526189
    [No Abstract]   [Full Text] [Related]  

  • 46. Short-course tuberculosis chemotherapy studies conducted in Poland during the past decade.
    Snider DE; Zierski M; Graczyk J; Bek E; Farer LS
    Eur J Respir Dis; 1986 Jan; 68(1):12-8. PubMed ID: 3512281
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tuberculosis: gynaecological tuberculosis.
    Sutherland AM
    Br J Hosp Med; 1979 Dec; 22(6):569-76. PubMed ID: 526692
    [No Abstract]   [Full Text] [Related]  

  • 48. [Preliminary results of initial short-term chemotherapy with INH, RMP and EMB in intermittent and biphasic administration (the 3 plus 6 experiment)].
    Anastasatu C; Bercea O; Barcan F; Stinghe R; Dinulică E; Marcovici M; Cristea M; Cărpinişan L; Gheorghiu M; Iancovici O; Ghinescu S
    Ftiziologia; 1974 May; 23(3):253-64. PubMed ID: 4842931
    [No Abstract]   [Full Text] [Related]  

  • 49. [Intermittent administration of streptomycin, isoniazid and ethambutol in pulmonary tuberculosis].
    Jesiotr M; Hoffman R; Klima E
    Harefuah; 1971 Jun; 80(12):639-40. PubMed ID: 5156426
    [No Abstract]   [Full Text] [Related]  

  • 50. Experimental "in vivo" studies of new antituberculosis drugs: capreomycin, ethambutol, rifampicin.
    Grumbach F
    Tubercle; 1969 Mar; 50():Suppl:12-21. PubMed ID: 5402543
    [No Abstract]   [Full Text] [Related]  

  • 51. [A controlled comparison of daily and intermittent triple drug regimens (SM-INH-EB) in original treatment. Report of the 16th series of Controlled Trial of Chemotherapy (author's transl)].
    Kekkaku; 1974 Aug; 49(8):247-52. PubMed ID: 4427402
    [No Abstract]   [Full Text] [Related]  

  • 52. [Effectiveness of various chemotherapy programs in patients with disseminated destructive pulmonary tuberculosis].
    Novikova TM
    Probl Tuberk; 1985; (2):66-7. PubMed ID: 4001099
    [No Abstract]   [Full Text] [Related]  

  • 53. [Treatment of newly diagnosed patients with infiltrative and disseminated pulmonary tuberculosis].
    Ursov IG; Krasnov VA; B1tashova VA; Kudelia OA; Volkova ZhA; Gromyko NI; Borovinskaia TA
    Probl Tuberk; 1998; (4):21-2. PubMed ID: 9771031
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The efficacy of the treatment of newly diagnosed patients with destructive tuberculosis of the lungs using rifampicin in combination with other drugs].
    Roslik SM; Pashkov IuN; Gerasimova TG; Marveeva SL
    Probl Tuberk; 1990; (5):75-6. PubMed ID: 2388900
    [No Abstract]   [Full Text] [Related]  

  • 55. [Short-term chemotherapy of tuberculosis. Cooperative French trial].
    Pretet S
    Rev Fr Mal Respir; 1983; 11(6):859-66. PubMed ID: 6366945
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modern treatment of tuberculosis.
    Dutt AK; Stead WW
    Compr Ther; 1982 Sep; 8(9):19-28. PubMed ID: 7140206
    [No Abstract]   [Full Text] [Related]  

  • 57. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Blood coagulation state in destructive pulmonary tuberculosis patients under different methods of chemotherapy].
    Sagalovich VIa; Beresneva RE; Ivanova VB
    Probl Tuberk; 1981 May; (5):30-4. PubMed ID: 7255385
    [No Abstract]   [Full Text] [Related]  

  • 59. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
    Shah AR; Agarwal SK; Shah KV
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Express intravenous administration of a complex of antituberculosis preparations in the treatment of destructive pulmonary tuberculosis].
    Bondarev IM; Zhigalina LI; Sokolova GB
    Probl Tuberk; 1977 Jul; (7):35-9. PubMed ID: 331307
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.